点击显示 收起
【摘要】 Mechanosensitive ion channels are thought to initiate pressure-induced vasoconstriction, however, the molecular identity of these channels is unknown. Recent work from our laboratory suggests that members of the Degenerin/Epithelial Na + Channel (DEG/ENaC) family may be components of the mechanosensitive ion channel complex in vascular smooth muscle (VSM); however, the specific DEG/ENaC proteins mediating myogenic constriction are unknown. The goal of this study is to determine if specific knockdown of or ENaC, using dominant-negative (DN) or small-interference RNA (siRNA) molecules, inhibits pressure-induced vasoconstriction in mouse renal interlobar arteries. To address this goal, isolated arteries were transiently transfected with or ENaC DN-cDNA or siRNA molecules. After 24 h, vessels were either 1 ) cannulated and pressurized for pressure-diameter response curves or 2 ) dissociated and immunolabeled to determine VSM cell endogenous ENaC protein expression. We found that transfection of ENaC DN-cDNA or siRNA suppresses -, but not ENaC protein expression. Similarly, ENaC DN-cDNA or siRNA suppresses -, but not ENaC protein expression. In addition, transfection of - or ENaC DN-cDNA or siRNA molecules inhibits pressure-induced vasoconstriction, but does not block agonist-induced vasoconstriction. Our results provide the first direct evidence that and ENaC proteins are essential in mediating myogenic vasoconstriction in mouse renal interlobar arteries.
【关键词】 mechanotransduction transfected isolated renal vessel stretchactivated cation channel siRNA dominant negative
VASCULAR SMOOTH MUSCLE CELLS (VSMC) from most small resistance arteries exhibit an innate ability to contract in response to elevations in intraluminal pressure. The active vasoconstriction is considered myogenic, or of muscular origin, typically occurring independently of neural, metabolic, or hormonal factors ( 7 ). Pressure-induced VSM membrane depolarization ( 6, 15, 23 ) and subsequent Ca 2+ influx via voltage-gated Ca 2+ channels largely mediate myogenic constriction ( 6, 22, 31 ). The response involves transduction of a mechanical stimulus (pressure-induced stretch) into a cellular event (depolarization/contraction). Although mechanosensitive nonselective cation channels are thought to initiate pressure-induced depolarization ( 6, 22, 31 ), the molecule(s) involved have not been fully characterized.
Members of the Degenerin/Epithelial Na + Channel (DEG/ENaC) family of proteins are candidates for mechanosensitive ion channels in vascular smooth muscle. Evidence suggests DEG/ENaC proteins may act as mechanosensors. First, members of this evolutionarily conserved family form mechanosensors in the nematode, Caenorhabditis elegans ( 26 ). Second, ENaC channels can be activated by shear stress, a mechanical factor ( 5, 28 ). Third, ENaC proteins are required for normal mechanosensation in a variety of mammalian cell types ( 3, 10, 13, 21, 25, 32 ). Through selective pharmacological inhibition of DEG/ENaC channels, our laboratory has recently provided evidence that DEG/ENaC channels play an important role in myogenic constriction in isolated, pressurized rat middle cerebral arteries ( 9 ) and mouse renal interlobar arteries ( 18 ). These pharmacological inhibitors have provided a basic tool to screen for DEG/ENaC channel involvement because they block a broad spectrum of DEG/ENaC channels. While we detected and, but not, ENaC transcripts and protein in freshly dispersed VSMCs from rat cerebral and mouse renal vessels ( 9, 18 ), direct evidence supporting a role of and/or ENaC in myogenic constriction is still lacking. The goal of this investigation was to determine whether the presence of and/or ENaC is important in eliciting myogenic constriction in renal interlobar arteries. To achieve this goal, we used novel approaches, dominant-negative (DN) and small-interference RNA (siRNA), to silence endogenous ENaC expression. Our findings provide the first direct evidence that - and ENaC are essential for myogenic vasoconstriction in mouse renal interlobar arteries.
MATERIALS AND METHODS
All protocols and procedures employed in this study were reviewed and approved by the Institutional Animal Care and Use Committee of the University of Mississippi Medical Center.
Preparation of dominant negative (DN) expression vectors and siRNA. The generation of our DN expression vectors has been previously described ( 8 ). Briefly, premature stop codons (X) were engineered into nucleotide bases encoding for amino acid I41 for ENaC (EGFP- I41X ) and L160 for ENaC (EGFP- L160X ) and ligated into Enhanced Green Fluorescent Protein C-terminal expression vector (pEGFP-C1). The EGFP expression vector was used as a negative control and EGFP fluorescence was used to identify transfection efficiency of the arteries ( Fig. 1 ) and VSMC ( Fig. 2 ).
Fig. 1. Enhanced green fluorescent protein (EGFP) expression in mouse renal interlobar arteries following transfection with EGFP-labeled dominant-negative (DN)-cDNA molecules. A : representative bright field ( right ) and fluorescence ( left ) images from mouse renal interlobar arteries. B : graph summarizes the whole vessel mean EGFP fluorescence intensity (F 488 ) expressed as relative units (RU) from arteries treated with Lipofectamine alone (Lfx control; n = 5), EGFP (empty vector; n = 5), EGFP- I41X ( n = 5), or EGFP- L160X ( n = 5). Values are represented as means ± SE. * P < 0.05 vs. Lfx control.
Fig. 2. Transfection of mouse renal interlobar arteries with ENaC DN-cDNA suppresses endogenous ENaC expression in dispersed mouse renal vascular smooth muscle cells (mrVSMC). Isolated arteries were transfected with Lipofectamine alone (Lfx control), EGFP (empty vector), EGFP- I41X or EGFP- L160X and dissociated mrVSMCs were labeled for -actin and or ENaC. A and C : representative images of dissociated mrVSMCs labeled with smooth muscle -actin (SM -actin, top row), EGFP ( middle row), and rabbit anti-ENaC ( bottom row) are shown at left. Group data for ( B ) and ENaC ( D ) immunofluorescence intensity normalized to -actin are shown at right. A and B : mrVSMCs from cells transfected with EGFP- I41X, but not EGFP- L160X, have suppressed ENaC immunostaining. C and D : mrVSMCs from cells transfected with EGFP- L160X, but not EGFP- I41X, have suppressed ENaC immunostaining. Data are means ± SE. The number of cells used for the analysis is indicated in each bar and was obtained from 3 different animals from separate experiments for each group. *Significantly different than Lfx and EGFP controls, P < 0.05. NS, not significantly different.
Small interfering RNA (siRNA) molecules designed against mouse ENaC (SCNN_1b; ID # 69163) and ENaC (SCNN_1g; ID # 151576) were obtained from Ambion (Austin, TX). As a control, we used a non-targeting siRNA (Dharmacon, Chicago, IL) which activates the RNA-induced silencing complex (RISC).
Transfection of renal interlobar arteries. To transfect renal interlobar arteries with DN-cDNA or siRNA, we used a modified protocol previously published by Kaide et al. ( 19 ). Briefly, male C57BL/6J mice (6-8 wks; Jackson Laboratory, Bar Harbor, ME) were anesthetized with halothane and decapitated. Kidneys were excised and placed in ice cold physiological saline solution [(PSS, pH adjusted to 7.4 with NaOH) containing (in mM) 130 NaCl, 4 KC1, 1.2 MgSO 4, 4 NaHCO 3, 1.8 CaC1 2, 10 HEPES, 1.18 KH 2 PO 4, 6 glucose, 0.03 EDTA]. Interlobar arteries were dissected from hemi-sected kidneys and transferred to a 35 mm culture dish and transiently transfected with the DN-cDNA (10 µg of EGFP, EGFP- I41X, or EGFP- L160x ) or siRNA (10 µg of non-targeting, ENaC, or ENaC) using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to manufacturer?s instructions. Additional vessels were incubated with Lipofectamine (Lfx) alone as a vehicle control. After 4 hrs, a 1:1 ratio of Dulbecco?s Modified Eagle Medium (DMEM):F-12 supplement (GIBCO Laboratories) containing 100U/ml penicillin/streptomycin was added to the vessels. The vessels were maintained in organ culture for 20-24 hrs in a humidified incubator (95% air-5% CO 2 ) at 37°C. At the end of the culture period, vessels were either used for vascular reactivity studies or were further dissociated for quantitative immunofluorescence studies.
ENaC immunofluorescence in dispersed VSMCs. To determine endogenous expression of - and ENaC following vessel transfection with - and ENaC DN-cDNA or siRNA, VSMCs were enzymatically dissociated from the isolated vessels and fixed as described previously ( 18 ). Anti-ENaC antibodies were raised in rabbits [beta mouse ENaC (617-638): NH 2 -CNYDSLRLQPLDTMESDSEVEAI-COOH, gamma mouse ENaC (618-639): NH 2 -CPAPEAPVPGTPPPRYNTLRLD-COOH, Sigma Genosys, Woodlands TX]. The ENaC antigenic sequence has 100% identity with rat and 90% identity with human isoforms. The ENaC antigenic sequence has 84% identity with rat and 79% identity with human isoforms. Antibodies were affinity purified against the original antigenic sequence (Sigma Genosys) and screened by ELISA, immunolabeling in COS-7 cells transfected with and ENaC cDNA and immunolabeling in VSMCs with antigen competition. Samples were labeled with rabbit anti- - or ENaC antibodies (1:100) and mouse anti-smooth muscle -actin (1:200) to identify VSMC and normalize immunofluorescence. Samples were examined using fluorescence confocal microscopy (TCS-SP2, Leica Microsystems, Exton, PA). To normalize data, - and ENaC fluorescence was divided by -actin fluorescence for each cell. All -actin-labeled cells were used for analysis independent of EGFP fluorescence. Data were averaged from 3 animals in each group.
Vascular reactivity. To determine vascular reactivity following transfection with - and/or ENaC DN-cDNA or siRNA, mouse renal interlobar arteries were cannulated and studied in a vessel chamber (CH/1/SH, Living Systems, Burlington, VT) and analyzed using MetaMorph software (Universal Imaging, Dowingtown, PA) as described previously ( 18 ). Following an initial incubation period (30 min; 75 mmHg), a concentration-response curve to phenylephrine (PE; 10-9-10-5 M) was generated in each vessel to determine vessel viability. Vessels with less than 60% maximal response (calculated as percent of baseline inner diameter) were excluded. After washing and re-equilibrating the vessel, a pressure-diameter curve was generated by exposing the interlobar arteries to step-wise increases in intraluminal pressure from 25 to 150 mmHg (25 mmHg steps, 5 min each). Then, arteries were equilibrated for 30 min with Ca2+-free PSS (same as above PSS plus 2 mM EGTA and omit 1.8 mM CaCl 2 ) to determine the passive pressure-diameter curve as described above. Change in diameter was calculated as the difference between the active (PSS) and passive (Ca2+-free PSS) inner diameter at each pressure. Data were averaged from 5 animals in each group. When more than one treated artery was used from a single animal, the results of the multiple experiments were averaged and included as a single value.
Statistics. All data are expressed as means ± SE. A one-way ANOVA and two-way ANOVA with repeated measures were used to make comparisons where appropriate. Differences among groups were compared using the Student-Newman-Keuls post hoc test. Statistical significance was considered at P < 0.05.
RESULTS
ENaC DN-cDNA or siRNA suppresses endogenous and ENaC protein expression in renal interlobar arteries. We used quantitative immunofluorescence to determine if or ENaC DN isoforms or siRNA suppresses ENaC protein. Representative images and quantitative group data are shown in Figs. 2 and 3. Compared with the Lfx and EGFP controls, transfection of EGFP- I41X reduced endogenous ENaC expression 60% ( Fig. 2, A and B ); and EGFP- L160X reduced endogenous ENaC expression 50% ( Fig. 2, C and D ). In addition, transfection with EGFP- I41X did not suppress endogenous ENaC expression ( Fig. 2, C and D ) nor did EGFP- L160X alter endogenous ENaC expression ( Fig. 2, A and B ). Similarly, compared with non-targeting siRNA controls, ENaC-siRNA suppressed 70% endogenous - ( Fig. 3, A and B ), but not ENaC ( Fig. 3, C and D ). In addition, ENaC-siRNA suppressed 60% endogenous - ( Fig. 3, C and D ), but not ENaC ( Fig. 3, A and B ). These data show DN and siRNA molecules selectively silence or ENaC expression in renal interlobar arteries.
Fig. 3. Transfection of mouse renal interlobar arteries with siRNA suppresses endogenous ENaC expression in dissociated mrVSMCs. Isolated arteries were transfected with nontargeting (NT), or ENaC specific siRNA molecules then dissociated mrVSMCs were labeled for -actin and or ENaC. A and C. Representative images from dissociated mrVSMCs labeled with smooth muscle -actin (SM -actin, top row) and ENaC ( bottom row) are shown at left. Group data for ( B ) and ENaC ( D ) immunofluorescence intensity normalized to -actin are shown at right. A and B : mrVSMCs from arteries transfected with ENaC, but not ENaC siRNA, have suppressed ENaC immunostaining. C and D : mrVSMCs from arteries transfected with ENaC, but not ENaC siRNA, have suppressed ENaC immunostaining. Data are means ± SE. Number of cells used for analysis is indicated in each bar and were collected from 3 different animals from separate experiments for each group. *Significantly different from NT control, P < 0.05. NS, not significantly different.
ENaC DN-cDNA or siRNA inhibits renal interlobar myogenic constriction. PE-induced vasoconstrictor responses are shown in Fig. 4 for DN ( Fig. 4 A ) and siRNA ( Fig. 4 B ) transfected arteries. PE elicited similar vasoconstrictor responses in all groups. This demonstrates suppression of endogenous ENaC does not alter vascular reactivity, per se. In contrast, transfection with and ENaC DN-cDNA and siRNA molecules dramatically inhibited pressure-induced constriction ( Fig. 5 and 6 ). Transfection with EGFP- L160X maximally inhibited 70% the myogenic response, while transfection with EGFP- I41X blocked 80% ( Fig. 5, C-E ). Compared with the Lipofectamine (Lfx) vehicle control, EGFP alone did not significantly alter myogenic tone ( Fig. 5, B and E ). As shown in Fig. 6, ENaC-siRNA and ENaC-siRNA significantly reduced myogenic constriction by 65 and 40%, respectively, in renal interlobar arteries compared with the non-targeting siRNA control.
Fig. 4. Agonist-induced reactivity is unaltered by or ENaC suppression in isolated mouse interlobar arteries. Vasoconstriction (expressed as percent of baseline diameter) to the 1-adgenergic receptor agonist, phenylephrine (PE; 10-9-10-5 M) following transfection with ( A ) Lipofectamine alone (Lfx Control), EGFP, EGFP- I41X, and EGFP- L160X; or ( B ) nontargeting, ENaC, and ENaC siRNA. Values are means ± SE ( n = 5 in each group).
Fig. 5. Transient transfection with ENaC DN-cDNA inhibits myogenic constriction in mouse renal interlobar arteries. A-D : Active (Ca 2+ -containing PSS; filled symbols) and passive (Ca 2+ -free PSS; open symbols) vessel inner diameter in response to increases in intraluminal pressure following transfection with Lipofectamine alone ( A, Lfx Control); EGFP ( B ), EGFP- I41X ( C ), and EGFP- L160X ( D ). E : summary of changes in vessel inner diameter (passive-active) for each group. Data are means ± SE, n = 5 animals per group. *Significantly different from Ca 2+ -free PSS, P < 0.05. Significantly different from Lfx control and EFGP, P < 0.05.
Fig. 6. Transient transfection with or ENaC siRNA inhibits myogenic constriction in mouse renal interlobar arteries. A-C : active (Ca 2+ -containing PSS; filled symbols) and passive (Ca 2+ -free PSS; open symbols) vessel inner diameter in response to increases in intraluminal pressure following transfection with nontargeting ( A ) ENaC ( B ) and ENaC ( C ) siRNA. D : Summary of changes in vessel inner diameter (passive-active) for each group. Data are mean ± SE. *Significantly different from Ca 2+ -free PSS, P < 0.05. Significantly different from nontargeting siRNA, P < 0.05.
DISCUSSION
Previous studies from our laboratory demonstrated that DEG/ENaC channel blockade abolished pressure induced vasoconstriction in rat middle cerebral arteries ( 9 ) and mouse interlobar arteries ( 18 ). Although these experiments provided evidence members of the DEG/ENaC family are required to mediate myogenic constriction, they did not identify which individual DEG/ENaC proteins are involved. The major finding of this investigation is that and ENaC expression in mouse renal interlobar arteries is required for myogenic constriction.
Until recently, mammalian ENaC proteins have been described mainly in kidney epithelial cells where they form constitutively active channels that play a rate limiting role in sodium absorption, and therefore, an essential role in the control of sodium balance, blood volume, and blood pressure ( 14, 20 ). However, our findings suggest that ENaC proteins in VSMCs may contribute to local blood flow regulation via myogenic constriction. This is a novel finding and one that supports the unique function of this protein family as mechanosensors. The involvement of DEG/ENaC in mechanotransduction has been shown in many other species and cell types ( 2, 12, 14, 20, 24 ); including mammalian dorsal root ganglion, arterial baroreflex sensory neurons, osteoblasts, keratinocytes, pain and touch receptors, and renal tubular cells ( 3, 10, 13, 21, 25, 28 ). Here, we provide evidence and ENaC proteins are also involved in mechanotransduction in VSMCs.
Similiar to previous findings from our lab, we found ( 9, 18 ), and ENaC expression is concentrated at or near the membrane, as indicated by colocalization with -actin. Previous work by ourselves and others show -actin staining is quite different in VSMCs that have been freshly dissociated compared with VSMCs maintained in culture ( 9, 18, 33 ). In VSMCs maintained in culture, -actin staining is filamentous and distributed through out the cell. However, in freshly dispersed VSMCs, -actin is concentrated near the membrane, making it an excellent marker of near-membrane proteins. In contrast to our previous findings, in the current study we detected more cytoplasmic localization of and ENaC protein, suggesting some redistribution of ENaC towards the cytoplasm. However, it is important to note that despite the presence of cytoplasmic ENaC expression, most ENaC expression is still localized to the membrane region. The factors accounting for the cytoplasmic localization of ENaC are unknown, but are most likely due to the overnight incubation period since this was the only methodological difference between the previous ( 18 ) and current studies. We speculate that substances present in the culturing media and/or the loss of transmural pressure in the arteries are contributing factors. In previous reports, we have shown a pronounced cytoplasmic staining pattern in renal VSMCs maintained in culture for a longer period (1-3 wk) ( 18 ). Taken together, these findings suggest that localization of ENaC proteins within the VSMC, i.e., cytoplasmic vs. membrane, is not "hard-wired", but can be influenced by the cells? environment. However, whether loss of transmural pressure and supplements in the culturing media are responsible for regulating ENaC localization remains to be determined.
Two approaches were used to determine if ENaC proteins are required for myogenic constriction; siRNA and dominant-negative ENaC isoforms. As expected, siRNA, a known posttranscriptional gene silencer, reduced protein levels of ENaC and ENaC by 50% 24 h after transfection. The effect of siRNA on ENaC channel activity per se cannot be determined from our investigation since electrophysiological measurements of channel activity were not made. However, our findings indicate the 50% reduction in immunoreactive protein levels of ENaC or ENaC resulted in an almost complete loss of the myogenic constrictor response. This indicates normal levels of both ENaC and ENaC protein are required for a normal myogenic constrictor response and further suggests they may interact or associate.
In addition to siRNA, we inhibited ENaC channel function using a DN approach. DN ENaC isoforms also inhibited and ENaC protein levels to a similar extent as siRNA, however, most likely by a different mechanism. The NH 2 -terminal fragment of a related degenerin family member, Mec-4, has been shown to inhibit the response to touch in C. elegans ( 17 ). A similar NH 2 -terminal fragment of ENaC has been shown to inhibit ENaC channel activity, most likely by associating with other full-length subunits to form nonfunctional channels ( 1 ). The improperly formed channels are thought to be unstable and degraded, the basis for a loss of channel activity. Based on this finding, we anticipated either DN-cDNA would inhibit protein levels of and ENaC. There are at least two possible explanations for these findings. First, and ENaC may form homomeric channels. However, we think this is unlikely given our finding that siRNA towards either subunit abolished 70-80% of the response. A second possibility is that the DN (EGFP- I41X ) interacts with its full-length ENaC counterpart prior to assembly or association with ENaC. Further studies are required to determine the mechanisms underlying DN inhibition of ENaC channel function.
A critical issue is whether ENaC and ENaC can form an ion-conducting pore in the absence of ENaC. In heterologous expression systems, evidence suggests ENaC and ENaC are capable of associating in the absence of ENaC. When coexpressed without ENaC, ENaC immunoprecipitates with ENaC, suggesting a biochemical association between ENaC and ENaC that persists in the absence ENaC. Using the Xenopus oocyte expression system, a report by Bonny et al. ( 2a ) demonstrates ENaC can generate amiloride-sensitive macroscopic currents after 6 days of incubation. A delayed trafficking of ENaC channels in the ooctye system may be the basis for difficulty in identifying currents generated by ENaC channels by others. Bonny et al.?s finding is significant because it demonstrates ENaC and ENaC are sufficient to form a pore. Alternatively, it is possible that another degenerin protein, such as an ASIC protein, also associates with ENaC and ENaC to form the pore of a channel in VSMCs.
Presently, there is no electrophysiological evidence that ENaC proteins form a channel in VSMCs. However, the presence of a non-voltage-gated, epithelial-like Na + channel in VSMCs was reported by Renterghem and Lazdunski 15 years ago ( 30 ). Similar to ENaC channels, the channel reported by Renterghem and Lazdunski exhibited high Na + selectivity, a 10-pS conductance and was not voltaged gated. Unlike ENaC channels, the VSMC channel was insensitive to amiloride, butsensitive to higher concentrations of phenamil, an amiloride analog. Since that time, the presence and importance of these channels have received little attention. Electrophysiologic evidence confirming the presence of ENaC channels in VSMCs remains an important area of future investigation.
In comparison to responses in freshly isolated renal interlobar arteries ( 18 ), a small loss of the myogenic constrictor response was observed in the transfection control experiments (Lfx, EGFP, NT-siRNA), particularly at higher pressures ( 100 mmHg). However, this is not surprising given the 24-h incubation period required to induce gene silencing. Although it may be coincidental, we speculate the depression of the myogenic constrictor response following the 24-h incubation may be related to the redistribution of and ENaC towards the cytoplasm noted previously. A redistribution of ENaC proteins towards the cytoplasm may reflect a reduction in the amount of active, membrane-associated ENaC channels contributing to signal transduction, which might be expected to lead to a reduction in myogenic tone development.
It is generally accepted that pressure-induced VSM membrane depolarization ( 6, 15, 23 ) and subsequent Ca 2+ influx via voltage-gated Ca 2+ channels largely mediates myogenic constriction ( 6, 22, 31 ). Many studies have followed this initial finding to determine a common signaling mechanism initiating the myogenic response. However, it has been difficult to ascribe myogenic constriction to a single mechanism because increased pressure activates multiple factors that influence VSM depolarization and their relative contribution varies immensely between, and even within, vascular beds ( 16 ). Potential mechanisms include pressure-induced activation of membrane-associated enzyme systems, ion transportors and mechanosensitive ion channels ( 7 ).
Although we do not know the precise function of ENaC proteins or whether their function is consistent across vascular beds, we speculate that ENaC subunits are part of a large complex, previously modeled in C. elegans ( 24 ). ENaC subunits form the pore of the channel in VSMCs and interact with extracellular matrix and cytoskeletal proteins to form a larger mechanosensitive complex. This speculation is supported by findings that demonstrate cytoskeletal and extracellular matrix proteins interact with certain DEG/ENaC proteins ( 2, 21, 24, 27 ). Furthermore, at least one cytoskeletal protein may be required to mechanically gate a mechanosensitive channel formed by DEG proteins in C. elegans ( 26 ). We further speculate that upon mechanical activation, the channel opens and allows influx of Na + and/or Ca 2+ ions, presumably leading to depolarization. While our laboratory has shown that inhibition of DEG/ENaC abolishes pressure-induced increases in cytosolic Na + and Ca 2+ ( 18 ), we have not yet correlated this to pressure-induced depolarization.
In the current investigation, we provide evidence ENaC proteins are involved in the myogenic response in the renal circulation. However, ENaCs may not contribute to myogenic responses in every vascular bed. The involvement of other mechanosensitive proteins, such as transient receptor potential channels ( 11, 29 ) or acid-sensing ion channels, may play a role in myogenic constriction in other beds. Results from these experiments identify a new group of proteins involved in vascular function; however, many fundamental mechanistic questions remain. How is the channel gated by mechanical stimuli? Does the channel interact with extracellular matrix or other degenerin proteins? How is the channel regulated by hormonal and autocrine factors?
GRANTS
This work is supported by National Institutes of Health Grants HL-082425 (N. Jernigan), HL-071603 (H. Drummond), AHA 0655305B (H. Drummond), and HL-51971.
ACKNOWLEDGMENTS
The authors thank A. Hoover for technical assistance and laboratory colleague S. Grifoni for assistance and discussion.
【参考文献】
Adams CM, Snyder PM, and Welsh MJ. Interactions between subunits of the human epithelial sodium channel. J Biol Chem 272: 27295-27300, 1997.
Benos DJ and Stanton BA. Functional domains within the degenerin/epithelial sodium channel (Deg/ENaC) superfamily of ion channels. J Physiol 520: 631-644, 1999.
Bonny O, Chraibi A, Loffing J, Jaeger N, Grunder S, Horisberger J, and Rossier B. Functional expression of a pseudohypoaldosteronism type I mutated epithelial Na + channel lacking the pore-forming region of its alpha subunit. J Clin Invest 104: 967-974, 1999.
Brouard M, Casado M, Djelidi S, Barrandon Y, and Farman N. Epithelial sodium channel in human epidermal keratinocytes: expression of its subunits and relation to sodium transport and differentiation. J Cell Sci 112: 3343-3352, 1999.
Canessa CM, Schild L, Buell G, Thorens B, Gautschi I, Horisberger JD, and Rossier BC. Amiloride-sensitive epithelial Na + channel is made of three homologous subunits. Nature 367: 463-467, 1994.
Carattino MD, Sheng S, and Kleyman TR. Epithelial Na + channels are activated by laminar shear stress. J Biol Chem 279: 4120-4126, 2004.
Davis MJ, Donovitz JA, and Hood JD. Stretch-activated single-channel and whole cell currents in vascular smooth muscle cells. Am J Physiol Cell Physiol 262: C1083-C1088, 1992.
Davis MJ and Hill MA. Signaling mechanisms underlying the vascular myogenic response. Physiol Rev 79: 387-423, 1999.
Drummond HA, Furtado MM, Myers S, Grifoni S, Parker KA, Hoover A, and Stec DE. ENaC proteins are required for NGF-induced neurite growth. Am J Physiol Cell Physiol 290: C404-C410, 2006.
Drummond HA, Gebremedhin D, and Harder DR. Degenerin/epithelial Na + channel proteins. Components of a vascular mechanosensor. Hypertension In press.
Drummond HA, Price MP, Welsh MJ, and Abboud FM. A molecular component of the arterial baroreceptor mechanotransducer. Neuron 21: 1435-1441, 1998.
Earley S, Waldron BJ, and Brayden JE. Critical role for transient receptor potential channel TRPM4 in myogenic constriction of cerebral arteries. Circ Res 95: 922-929, 2004.
Garcia-Anoveros J and Corey DP. The molecules of mechanosensation. Annu Rev Neurosci 20: 567-594, 1997.
Garcia-Anoveros J, Samad TA, Zuvela-Jelaska L, Woolf CJ, and Corey DP. Transport and localization of the DEG/ENaC ion channel BNaC1alpha to peripheral mechanosensory terminals of dorsal root ganglia neurons. J Neurosci 21: 2678-2686, 2001.
Garty H and Palmer LG. Epithelial sodium channels: function, structure, and regulation. Physiol Rev 77: 359-396, 1997.
Harder DR. Pressure-dependent membrane depolarization in cat middle cerebral artery. Circ Res 55: 197-202, 1984.
Hill MA, Zou H, Potocnik SJ, Meininger GA, and Davis MJ. Invited review: arteriolar smooth muscle mechanotransduction: Ca 2+ signaling pathways underlying myogenic reactivity. J Appl Physiol 91: 973-983, 2001.
Hong K, Mano I, and Driscoll M. In vivo structure-function analyses of Caenorhabditis elegans MEC-4, a candidate mechanosensory ion channel subunit. J Neurosci 20: 2575-2588, 2000.
Jernigan NL and Drummond HA. Vascular ENaC proteins are required for renal myogenic constriction. Am J Physiol Renal Physiol In press.
Kaide J, Wang MH, Wang JS, Zhang F, Gopal VR, Falck JR, Nasjletti A, and Laniado-Schwartzman M. Transfection of CYP4A1 cDNA increases vascular reactivity in renal interlobar arteries. Am J Physiol Renal Physiol 284: F51-F56, 2003.
Kellenberger S and Schild L. Epithelial sodium channel/degenerin family of ion channels: a variety of functions for a shared structure. Physiol Rev 82: 735-767, 2002.
Kizer N, Guo XL, and Hruska K. Reconstitution of stretch-activated cation channels by expression of the -subunit of the epithelial sodium channel cloned from osteoblasts. Proc Natl Acad Sci USA 94: 1013-1018, 1997.
Knot HJ and Nelson MT. Regulation of arterial diameter and wall [Ca 2+ ] in cerebral arteries of rat by membrane potential and intravascular pressure. J Physiol 508: 199-209, 1998.
Knot HJ and Nelson MT. Regulation of membrane potential and diameter by voltage-dependent K+ channels in rabbit myogenic cerebral arteries. Am J Physiol Heart Circ Physiol 269: H348-H355, 1995.
Mano I and Driscoll M. DEG/ENaC channels: a touchy superfamily that watches its salt. Bioessays 21: 568-578, 1999. <a href="/cgi/external_ref?access_num=10.1002/(SICI)1521-1878(199907)21:7
McCarter GC, Reichling DB, and Levine JD. Mechanical transduction by rat dorsal root ganglion neurons in vitro. Neurosci Lett 273: 179-182, 1999.
O?Hagan R, Chalfie M, and Goodman MB. The MEC-4 DEG/ENaC channel of Caenorhabditis elegans touch receptor neurons transduces mechanical signals. Nat Neurosci 8: 43-50, 2005.
Price MP, Thompson RJ, Eshcol JO, Wemmie JA, and Benson CJ. Stomatin modulates gating of acid-sensing ion channels. J Biol Chem 279: 53886-53891, 2004.
Satlin LM, Sheng S, Woda CB, and Kleyman TR. Epithelial Na + channels are regulated by flow. Am J Physiol Renal Physiol 280: F1010-F1018, 2001.
Scotland RS, Chauhan S, Davis C, De Felipe C, Hunt S, Kabir J, Kotsonis P, Oh U, and Ahluwalia A. Vanilloid receptor TRPV1, sensory C-fibers, and vascular autoregulation: a novel mechanism involved in myogenic constriction. Circ Res 95: 1027-1034, 2004.
Van Renterghem C and Lazdunski M. A new nonvoltage-dependent, epithelial-like Na+ channel in vascular smooth muscle cells. Pflügers Arch 419: 401-408, 1991.
VanBavel E, Wesselman JP, and Spaan JA. Myogenic activation and calcium sensitivity of cannulated rat mesenteric small arteries. Circ Res 82: 210-220, 1998.
Welsh MJ, Price MP, and Xie J. Biochemical basis of touch perception: mechanosensory function of degenerin/epithelial Na + channels. J Biol Chem 277: 2369-2372, 2002.
Yakubovich N, Eldstrom JR, and Mathers DA. Lipopolysaccharide can activate BK channels of arterial smooth muscle in the absence of iNOS expression. Biochim Biophys Acta 1514: 239-252, 2001.
作者单位：Department of Physiology and Biophysics and the Center for Excellence in Cardiovascular Renal Research, University of Mississippi Medical Center, Jackson, Mississippi